Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: A [60]fullerene nanoconjugate with gemcitabine: synthesis, biophysical properties and biological evaluation for treating pancreatic cancer

Fig. 5

Effect of the tested nanoC60GEM (35 and 17 µM) and GEM (1.5 and 0.75 µM) on regulating the cell cycle in the PAN02 cell line. The histograms show the distribution of the cells in the G0/G1, S and G2/M phases of the cell cycle for an exemplary experiment (a). The table shows the mean ± SD percentage of the cells in the G0/G1, S and G2/M phases of the cell cycle from three independent experiments (b). The data were analyzed using a one-way ANOVA with a Bonferroni’s post hoc test: *p < 0.05, **p < 0.01, ***p < 0.001 compared to the control (c)

Back to article page